A Study of Remternetug (LY3372993) in Healthy Chinese Participants
Clinical trial NCT07346495 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07346495
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2026-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.